Farxiga
Pricing Report NDC 0003-1428-11

View Wholesale Price per Unit, Acquisition Costs, and Historic Pricing Trends
Table of Contents
  1. Current Pricing Information
  2. Pricing History

Current Package Pricing Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

The latest wholesale acquisition cost for Farxiga (NDC 0003-1428-11) is $13.78011 per EA. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Mar 22, 2017.

As a provided by E.r. Squibb & Sons, L.l.c., this medication is distributed in a 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$13.78011
Per EA

Pricing Unit
Per EA Pricing Unit
Indicates the billing unit (ML, GM or EA).
Effective Date
Mar 22, 2017
Billable Units
30 EA
Estimated Package Price
$413.40
Data Status
As of Aug 30, 2017
Pharmacy Source Pharmacy Type Indicator
Data collected from Chain/Independent pharmacy surveys.
C/I - Chain or Independent Pharmacy
Rate Classification Classification for Rate Setting
Indicates if the NDC is Brand (B) or Generic (G).
B - Brand
Package NDC
0003-1428-11
Description
30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC
Pricing Methodology Explanation
The average acquisition cost of the most recent survey was within ± 2% of the current NADAC; therefore, the NADAC was carried forward from the previous file.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Apr 2014, the NADAC wholesale price for (NDC ) has moved within a range of $9.30170 to $13.80391 per EA. Over this 2 years and 10 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$9.3017 - $13.8039
Market Volatility
48.40% Variance
Latest Trend
0.17%
Date Unit Price Unit Source Method Rate
Mar 22, 2017 $13.78011 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Mar 22, 2017 $13.78011 EAC/I - Chain or Independent PharmacyCode 2B - Brand
Feb 22, 2017 $13.80391 EAC/I - Chain or Independent PharmacyCode 3B - Brand
Jan 18, 2017 $13.79445 EAC/I - Chain or Independent PharmacyCode 3B - Brand
Apr 11, 2016 $12.62274 EAC/I - Chain or Independent PharmacyCode 2B - Brand
Apr 11, 2016 $12.62274 EAC/I - Chain or Independent PharmacyCode 3B - Brand
Oct 01, 2015 $11.69888 EAC/I - Chain or Independent PharmacyCode 2B - Brand
Oct 01, 2015 $11.69888 EAC/I - Chain or Independent PharmacyCode 3B - Brand
Aug 19, 2015 $11.05023 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Aug 19, 2015 $11.05023 EAC/I - Chain or Independent PharmacyCode 2B - Brand
Apr 22, 2015 $11.02592 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Apr 22, 2015 $11.02592 EAC/I - Chain or Independent PharmacyCode 2B - Brand
Feb 16, 2015 $11.08811 EAC/I - Chain or Independent PharmacyCode 2B - Brand
Feb 16, 2015 $11.08811 EAC/I - Chain or Independent PharmacyCode 3B - Brand
Oct 22, 2014 $10.08936 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Oct 22, 2014 $10.08936 EAC/I - Chain or Independent PharmacyCode 2B - Brand
Oct 22, 2014 $10.08936 EAC/I - Chain or Independent PharmacyCode 4B - Brand
Aug 15, 2014 $10.04581 EAC/I - Chain or Independent PharmacyCode 2B - Brand
Aug 15, 2014 $10.04581 EAC/I - Chain or Independent PharmacyCode 3B - Brand
May 21, 2014 $9.31021 EAC/I - Chain or Independent PharmacyCode 1B - Brand
May 21, 2014 $9.31021 EAC/I - Chain or Independent PharmacyCode 2B - Brand
Apr 23, 2014 $9.30170 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 2: The average acquisition cost of the most recent survey was within ± 2% of the current NADAC; therefore, the NADAC was carried forward from the previous file.
  • Code 3: The NADAC based on survey data has been adjusted to reflect changes in published pricing, or as a result of an inquiry to the help desk.
  • Code 4: The NADAC was carried forward from the previous file.
  • Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.

Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: July 08, 2026